NasdaqGS:ABCLLife Sciences
Will AbCellera Biologics' (ABCL) CMO Appointment Accelerate Its Internal Pipeline's Path to Market?
AbCellera Biologics recently appointed Dr. Sarah Noonberg as Chief Medical Officer, bringing over two decades of clinical development experience and a successful track record in pharmaceutical leadership.
Dr. Noonberg’s appointment highlights AbCellera’s commitment to advancing its antibody-based therapeutics pipeline and may broaden its expertise in global regulatory processes and commercialization strategies.
We'll explore how Dr. Noonberg’s clinical leadership could impact AbCellera’s...